SIR-2.3/SIRT4 loss enhances proteostasis and neuronal resilience via AMPK-induced autophagy in Huntington’s disease models

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Koyuncu, S.
  • Gómez-Escribano, A.P.
  • Mora, C.
  • Néri, C.
  • Dos Ramos, Y.
  • Vílchez, D.

Grupos

Abstract

Huntington’s disease (HD) is a neurodegenerative disorder caused by mutations in the huntingtin gene resulting in an extended polyglutamine (polyQ) stretch in the protein, which is prone to aggregation and toxicity. In addition to a proteostasis imbalance, growing evidence highlights the role of mitochondrial dysfunction in HD progression. Here we explore the role of SIR-2.3/SIRT4, a mitochondrial sirtuin, in polyQ-expanded peptides and mutant huntingtin (mHTT) toxicity using C. elegans and mammalian models. Notably, loss of sir-2.3 function results in neuronal protection mediated by AMPK activation and enhanced autophagy. These neuroprotective effects require the transcription factors DAF-16/FOXO and NHR-49, which regulate autophagy and metabolism. To explore the translational potential of these findings, we used soft ATP synthase inhibitors to mimic sir-2.3 ablation, successfully reducing mHTT-induced neuronal toxicity. These results identify the SIRT4-AMPK axis as a critical regulator linking mitochondrial metabolism, autophagy, and neuronal homeostasis in HD. These findings not only advance our understanding of HD pathogenesis but also offer promising therapeutic targets for restoring proteostasis and neuronal resilience capacity against neurodegenerative diseases. © The Author(s) 2026.

Datos de la publicación

ISSN/ISSNe:
1478-811X, 1478-811X

Cell Communication and Signaling  BMC

Tipo:
Article
Páginas:
-
PubMed:
41535947
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
1,710 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 1

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • huntingtin; polyglutamine; proton transporting adenosine triphosphate synthase; sirtuin; transcription factor; adult; animal cell; animal experiment; animal model; animal tissue; article; autophagy (cellular); Caenorhabditis elegans; controlled study; human; human cell; Huntington chorea; mitochondrial respiration; mouse; nerve cell; neuroprotection; neurotoxicity; nonhuman; protein homeostasis

Proyectos y Estudios Clínicos

MODFAT-HD-Modulators of fat metabolism as druggable targets to treat Huntington Disease.

Investigador Principal: RAFAEL VÁZQUEZ MANRIQUE

PCI2021-122099-2B . COMISION EUROPEA . 2022

Cita

Compartir